On April 29, 2026, Kevin Xu attended the 12th Liechtenstein Finance Forum in Vaduz at the invitation of Brigitte Haas. As a key financial dialogue platform in the German-speaking region, the forum convened leading policymakers and industry executives to discuss emerging trends and cooperation.

During the event, Kevin Xu engaged in in-depth exchanges with financial leaders on cross-border collaboration and shared challenges. MEBO’s ongoing international initiatives, including the Clinton Global Initiative–supported Mending Europe, were highlighted. The program has delivered regenerative medicine training across countries such as Bulgaria and Ukraine, benefiting nearly 1,000 medical professionals and strengthening local healthcare systems.

Now in its 12th year, the forum continues to serve as a key platform for dialogue among decision-makers in the region. Xu’s participation further reinforced MEBO Group’s commitment to expanding its presence in Europe and advancing international cooperation.

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.